European Journal of Cancer · 2015 · 25 citations · 30 references
MedicineCancer BiologyOncologyCancer GeneticsGynecologic OncologyMolecular OncologyBiomarker-guided Therapy SelectionCancer BiomarkersCancer GenomicsCancer Molecular PathologyMolecular Tumor ProfilingOvarian CancerBiomarkersBrca MutationsOvarian Cancer BiomarkersOvarian Cancer Prognostic BiomarkersOvarian Tumor BiomarkersParp InhibitionParp Inhibitor ResistanceParp Inhibitor Sensitivity
30
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Hannah Farmer, Nuala McCabe, Christopher J. Lord et al. · Nature · 2005 · 6.7K citations
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
Mansoor R. Mirza, Bradley J. Monk, Jørn Herrstedt et al. · New England Journal of Medicine · 2016 · 2.5K citations · Full text
Medicine, Oncology, Pharmacotherapy +15
Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
Jonathan A. Ledermann, Philipp Harter, Charlie Gourley et al. · New England Journal of Medicine · 2012 · 1.9K citations
Medicine, Oncology, Pharmacology +14
Robert L. Coleman, Amit M. Oza, Domenica Lorusso et al. · The Lancet · 2017 · 1.7K citations · Full text
Medicine, Gynecology, Oncology +12